Shareholders' equity · 2011–2025
Ionis Pharmaceuticals shareholders' equity
$489M−16.9% · FY2025
Ionis Pharmaceuticals (IONS) reported $489M in shareholders' equity for fiscal 2025, −16.9% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $489M | −16.9% | Open → |
| FY20242024-12-31 | $588M | +52.2% | Open → |
| FY20232023-12-31 | $387M | −32.5% | Open → |
| FY20222022-12-31 | $573M | −25.8% | Open → |
| FY20212021-12-31 | $772M | +3.8% | Open → |
| FY20202020-12-31 | $743M | −49.5% | Open → |
| FY20192019-12-31 | $1.5B | +40.4% | Open → |
| FY20182018-12-31 | $1.0B | +273.0% | Open → |
| FY20172017-12-31 | $281M | +182.2% | Open → |
| FY20162016-12-31 | $99.6M | −50.4% | Open → |
| FY20152015-12-31 | $201M | −22.1% | Open → |
| FY20142014-12-31 | $258M | −31.9% | Open → |
| FY20132013-12-31 | $378M | +107.0% | Open → |
| FY20122012-12-31 | $183M | +6.6% | Open → |
| FY20112011-12-31 | $171M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +7.8%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ionis Pharmaceuticals shareholders' equity |url=https://companiesranked.com/en/company/ionis-pharmaceuticals/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ionis Pharmaceuticals shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/ionis-pharmaceuticals/shareholders-equityBibTeX
@misc{companiesranked-en-company-ionis-pharmaceuticals-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Ionis Pharmaceuticals shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ionis-pharmaceuticals/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0000874015-26-000251 · July 29, 2026
{{cite web |title=Ionis Pharmaceuticals shareholders' equity — 10-Q (0000874015-26-000251) |url=https://www.sec.gov/Archives/edgar/data/874015/000087401526000251/form10q.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-29}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.